Phase 2 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who had a previous single-baby pregnancy that ended in a serious complication — such as early birth before 37 weeks, a baby born smaller than expected (below the 10th percentile for weight), severe preeclampsia, or a pregnancy loss after 20 weeks — as confirmed by an obstetrician
- People whose placenta from that previous complicated pregnancy showed a specific type of damage (called maternal vascular malperfusion), as confirmed by a specialist placenta pathologist
- People who are currently pregnant with one baby and are less than 16 weeks and 6 days along in the pregnancy
Who may not be able to join:
- People for whom blood-thinning medication (such as warfarin, enoxaparin, or heparin) is already planned during the current pregnancy
- People whose current baby has been found to have a significant birth defect
- People who have a medical reason why the blood-thinning drug enoxaparin would not be safe for them — for example, active serious bleeding, a low platelet count (below 100), or a known allergy to enoxaparin, heparin, or pork-derived products, or to benzyl alcohol
- People with chronic kidney disease where kidney function is significantly reduced (eGFR below 60) (confirm with trial site)
- People with known ongoing liver disease where certain liver enzyme levels are more than three times higher than normal
- People who have an artificial (mechanical) heart valve
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sunitha Suresh, Endeavor Health
Phone: (847) 570-2860
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite Adverse Pregnancy outcome
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.